| Dokumendiregister | Ravimiamet |
| Viit | REP-1/1883-2 |
| Registreeritud | 23.05.2024 |
| Sünkroonitud | 24.05.2024 |
| Liik | Väljaminev kiri |
| Funktsioon | REP Euroopa Farmakopöaga seotud asjaajamine |
| Sari | REP-1 Euroopa Farmakopöa alane kirjavahetus |
| Toimik | REP-1/2024 |
| Juurdepääsupiirang | Avalik |
| Juurdepääsupiirang | |
| Adressaat | European Directorate for the Quality of Medicines & HealthCare |
| Saabumis/saatmisviis | European Directorate for the Quality of Medicines & HealthCare |
| Vastutaja | Signe Leito (RA, Labor) |
| Originaal | Ava uues aknas |
Addition to the work programme of the EXP working party: Specific guidance for excipients for certain routes of administration
page 1 / 3
Q1-4 (3152)
NPA: (43796) Type: (!/list-dropdown)
A10 - Estonia (EE)
Please inform if you are in favour of the addition of the general chapter to the work
programme: (43797) Type: (L/list-radio)
In favour of the addition to the work programme
A1
If opposed to this addition to the work programme, please state why: (43798) Type: (T/text-long)
n.a
page 2 / 3
Remarks: (43800) Type: (T/text-long)
-
Powered by TCPDF (www.tcpdf.org)
page 3 / 3
| Nimi | K.p. | Δ | Viit | Tüüp | Org | Osapooled |
|---|---|---|---|---|---|---|
| Farmakopöa tööplaani asjus | 23.05.2024 | 1 | REP-1/1883-1 | Sissetulev kiri | ra | European Directorate for the Quality of Medicines & HealthCare |